Nukkleus Inc. Announces Pricing of SC II, its Corporate-Sponsored SPAC, at $10.00 per Unit
Nukkleus (NASDAQ:NUKK) announced the pricing of SC II Acquisition Corp. units at $10.00 per unit for an initial public offering expected to raise $150 million in gross proceeds, with an underwriter option for an additional $22.5 million.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nukkleus (NASDAQ:NUKK) announced the pricing of SC II Acquisition Corp. units at $10.00 per unit for an initial public offering expected to raise $150 million in gross proceeds, with an underwriter option for an additional $22.5 million. Each unit contains one Class A ordinary share and a right to receive one fifth (1/5) of a Class A ordinary share upon consummation of an initial business combination. Units will trade on the Nasdaq Global Market under the ticker SCIIU, and the offering is expected to close on or about November 28, 2025. The Sponsor, majority-owned by Nukkleus, will acquire 255,000 sponsor units at $10.00 each. Menachem Shalom is CEO of both Nukkleus and SC II.
Positive
- $150.0M expected gross proceeds from IPO
- Underwriters may add up to $22.5M via option
- Sponsor committed to buy 255,000 units for $2.55M
- Units to list on Nasdaq Global Market as SCIIU
Negative
- Each unit includes rights to 1/5 of a share, complicating post‑combination share count
- Underwriter option could raise total offering to $172.5M, increasing float
Details
News Market Reaction – NUKK
On Nov 26, the day this news came out, NUKK closed 8.90% below the previous close.
Data tracked by StockTitan Argus for the Nov 26 session.
Key Figures
- IPO unit price
- $10.00 per unit
- SC II initial public offering pricing
- Expected gross proceeds
- $150 million
- SC II IPO gross proceeds target from unit sales
- Underwriters’ option
- $22.5 million
- Option to purchase additional SC II units in IPO
- Sponsor Units
- 255,000 units
- Sponsor private placement units at $10.00 each
- Sponsor unit price
- $10.00 per Sponsor Unit
- Price for Sponsor’s private placement Units in SC II
- Unit right conversion
- 1/5 Class A share
- Right per unit upon completion of initial business combination
- IPO closing date
- November 28, 2025
- Expected closing date of SC II initial public offering
Historical Context
-
SC II IPO closed raising $172.5M with sponsor purchasing units.
-
SC II units priced at $10.00 aiming to raise $150M plus option.
-
Special meeting set to approve Star 26 Capital acquisition and share issuances.
-
Iron Dome funding boost highlighted as opportunity for Rimon and Nukkleus strategy.
-
Milipol Paris showcase of integrated A&D and AI technologies.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
special purpose acquisition company financial
initial public offering financial
prospectus regulatory
registration statement regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Nukkleus, Inc. (NASDAQ:NUKK) (“Nukkleus” or the “Company”), a strategic acquirer and developer of high-potential businesses in the aerospace and defense (A&D) industry, today announced the pricing of the initial public offering of the newly formed special purpose acquisition company, SC II Acquisition Corp. (“SC II”), for which the Company is the majority owner of SC II’s sponsor.
SC II expects to raise gross proceeds of
SC Capital II Sponsor LLC, a Delaware limited liability company and indirect subsidiary of the Company (the “Sponsor”), in which the Company holds a majority interest, is acting as the sponsor of SC II. Simultaneously with the closing of the initial public offering, pursuant to a Sponsor Private Placement Units Purchase Agreement, dated November 25, 2025, by and between SC II and the Sponsor, the Sponsor will acquire 255,000 Units (the “Sponsor Units”) at a price of
D. Boral Capital LLC is acting as the sole book-running manager for the initial public offering.
Additional Information About the Initial Public Offering and Where to Find it
A registration statement relating to the SC II initial public offering became effective on November 25, 2025. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the SC II securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The SC II initial public offering is being made only by means of a prospectus. When available, copies of the prospectus relating to the offering may be obtained from D. Boral Capital LLC: Attn: 590 Madison Avenue 39th Floor, New York, NY 10022, or by email at info@dboralcapital.com , or by telephone at (212) 970-5150, or from the U.S. Securities and Exchange Commission’s website at www.sec.gov.
About Nukkleus Inc.
Nukkleus Inc. (NASDAQ: NUKK) focuses on acquiring and scaling mission-critical suppliers across the defense, aerospace, and advanced manufacturing sectors. Nukkleus targets Tier 2 and Tier 3 companies that form the industrial backbone of national security infrastructure in the U.S., Israel and Europe. Through its proprietary capital model, Nukkleus integrates operational capabilities, financial discipline, and long-term vision to modernize and expand strategic suppliers, supporting dual-use innovation and resilient supply chains.
The Company’s portfolio approach combines organic growth with disciplined M&A, enabling transformational scale and positioning Nukkleus at the core of 21st-century defense industrial strategy.
Forward Looking Statements
Certain statements in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding the exercise of the overallotment option by the underwriters, and the prospects of completing a future business combination. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. Except as required by law, the Company and SC II undertake no obligation to update or revise any forward-looking statements.
For more information, please contact:
Investor Relations Contacts (US)
The Equity Group Inc.
Lena Cati
Tel: +1 212 836-9611
lcati@theequitygroup.com
Val Ferraro
Tel: +1 212 836-9612
vferraro@theequitygroup.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.